KRAS and pancreatic adenocarcinoma: It was also found that codon 12 was involved in majority of KRAS mutations.[22] Many gene knockdown studies in multiple cancer cell lines utilising RNAi and CRISPR techniques have demonstrated that KRAS mutant pancreatic adenocarcinoma cells are more sensitive to the loss of the KRAS oncogene than KRAS WT cancer cell lines.